Meet the VPR
Dr. Andrew S. Weyrich currently serves as the Vice President for Research (VPR) and the President of the University of Utah’s Research Foundation (UURF). He is also a Professor of Internal Medicine and holds an H.A. & Edna Benning Presidential Endowed Chair.
Education & Research
Born and raised in Dayton, Ohio, Dr. Andrew S. Weyrich received his B.S. degree in Biology from Baldwin-Wallace College, his M.S. degree in Health & Exercise Science from Wake Forest University, and his Ph.D. in Physiology & Pharmacology from the Bowman Gray School of Medicine. In 1991, Dr. Weyrich was a postdoctoral fellow at Thomas Jefferson University in Philadelphia where he studied the roles of adhesion molecules in ischemia-reperfusion injury. He joined the University of Utah (UU) in 1993 as a postdoctoral fellow before the faculty in the Department of Internal Medicine. He has referred to the UU as his home for almost 30 years.
Throughout his tenure at the UU, Dr. Weyrich’s research lab has focused on how blood clots form and regulate health and disease. His group made the seminal discovery in 2005 that anucleate human platelets splice precursor messenger RNA (mRNA) into products that regulate inflammation. This paradigm shifting observation revolutionized the field of hematology, and has led to thousands of studies that use mRNA profiling to understand how platelets regulate thrombosis and inflammation - which is now referred to as "thromboinflammation".
Dr. Weyrich has published nearly 200 peer-reviewed articles, book chapters and reviews and has been funded by the National Institute of Health (NIH) for over 25 years. He’s the recipient of numerous investigator research awards from organizations such as the Arteriosclerosis, Thrombosis and Vascular Biology (ATVB), the International Society of Thrombosis and Haemostasis (ISTH), and the American Society of Hematology (ASH) that honored him with the prestigious William Dameshek prize. He is also member of the esteemed Benning Society through his H.A. and Edna Benning Presidential Endowed Chair and, and he recently received the John R. Hoidal Senior Investigator Award.
Leading U Research to New Heights
Prior to his current position as Vice President for Research, Dr. Weyrich was the Associate Dean for Research at the School of Medicine. He also served as the Interim Director of the Molecular Medicine Program and Interim Associate Vice President for Research at Health Sciences in 2017-2018.
Since assuming his role as VPR in June 2016, Dr. Weyrich has led the UU’s research community to new heights. The UU’s research portfolio has substantially grown each year and continues to move in an upward trajectory. In FY20, the UU reached a remarkable milestone of over $600M in research funding and over 2,400 awarded grants – the highest record in the UU’s history. In addition to research growth, the UU was invited into the Association of American Universities (AAU), a prestigious group of universities that limits membership to institutes at the forefront of scientific inquiry. The UU was also recently awarded the Innovation and Economic Prosperity designation from the Association of Public and Land Grant Universities (APLU), which recognizes universities that promote growth, innovation, and economic development in their regions.
Oversight and Strategic Initiatives
Dr. Weyrich oversees 18 research administrative units that ensure research compliance and regulation and support faculty and student scientific activities across campus. In addition, Dr. Weyrich is the President of the UURF which cultivates research innovation and technology transfer as well as promote the university’s real estate prospects and industry partnerships.
Growing up playing sports and attending college on an academic scholarship, Andy has always been a devoted college sports fan. He is an avid supporter of UU athletics and musical theatre, where he is regularly found in the stands of games and the audience of musical performances. Andy and his wife, Amy, are strong community advocates for children and youth with disabilities. Andy’s advocacy work stems from his son, Sam, who was born with a rare leukodystrophy, Aicardi-Goutières.
In his spare time, Andy enjoys playing rhythm guitar. He and his former band, Stella, were privileged to play at the 2002 Olympics and Paralympics in Salt Lake City, and they volunteered to play in over 50 fundraising events for charitable organizations. Today Andy relishes traveling with his family and running with his son Sam.